Marieke JH Coenen

Affiliations: 
Human Genetics Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands 
Google:
"Marieke Coenen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sieberts SK, Zhu F, García-García J, et al. (2016) Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nature Communications. 7: 12460
Ramakers BP, Giamarellos-Bourboulis EJ, Tasioudis C, et al. (2015) Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction and Mortality in Sepsis Patients. Shock (Augusta, Ga.)
Bossini-Castillo L, de Kovel C, Kallberg H, et al. (2015) A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Annals of the Rheumatic Diseases. 74: e15
Broekman MM, Coenen MJ, Franke B, et al. (2015) Sa1249 Azathioprine and 6-Mercaptopurine Are Equally Effective in Thiopurine Naïve IBD Patients Gastroenterology. 148
Coenen M, Marrewijk Cv, Derijks L, et al. (2014) OP006 Personalized thiopurine dosing based on TPMT genotyping reduces leucopenia occurrence and results in cost-savings in IBD patients. Results from a randomized trial in the Netherlands Journal of Crohn's and Colitis. 8: 4
Umiċeviċ Mirkov M, Cui J, Vermeulen SH, et al. (2013) Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 72: 1375-81
Ramakers B, Giamarellos-Bourboulis E, Coenen M, et al. (2013) Effects of the common 34C>T variant of the AMPD1 gene on immune function, multiorgan dysfunction and mortality in patients with sepsis Critical Care. 17: 17
Coenen MJ, Marrewijk CJv, Derijks L, et al. (2013) P343 TPMT genotyping before thiopurine treatment results in lower leucopenia occurrence in a prospective randomized strategy study in 850 patients with inflammatory bowel disease Journal of Crohn's and Colitis. 7
Toonen EJ, Barrera P, Fransen J, et al. (2012) Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis. Arthritis Research & Therapy. 14: R264
Broen JC, Dieude P, Vonk MC, et al. (2012) Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression. The Journal of Rheumatology. 39: 112-8
See more...